Dr. Chang is a radiation oncology specialist with expertise in treating patients with breast cancer and pediatric cancer patients with proton beam therapy. He is also extensively involved in research and is the Principal Investigator in an ongoing multi-institutional trial utilizing proton therapy for partial breast irradiation. Before coming onboard at California Protons, he served as the director of the pediatric programs at the Hampton University Proton Therapy Institute, the Midwest Proton Radiotherapy Institute, as well as the ProCure proton therapy center. He completed a pediatric internship and residency in radiation oncology at Loma Linda University Medical Center and subsequently did a fellowship in pediatric oncology at St. Jude Children’s Hospital.
Clinical Research Associate:
Edith received her Bachelor’s degree from Northern Illinois University. She has 5 years of oncology research experience in numerous phase II and Phase III clinical trials for solid and hematological diseases. She also has experience coordinating specialized external and systemic radiation studies for Neurological, Head & Neck and Blood cancers. Most recently she worked as a clinical research coordinator for Northwestern Medicine Cancer Centers in Chicago’s West Region.
Mary Beth Henry
Mary Beth received her BS in Marketing from Northern Illinois University. Mary Beth has over 40 years of experience in Marketing and IT, and most recently she worked for Northwestern Medicine’s psychosocial oncology program for 11 years.
Robert Miller, MD
The primary research activities of Robert C. Miller, M.D., are focused on testing existing medications to determine if they can be used to reduce the negative symptoms associated with radiotherapy. This is being done through a series of national, multi-institutional phase III randomized controlled trials performed through the Alliance for Clinical Trials in Oncology. Additionally, Dr. Miller is leading the design of clinical trials for the Mayo Clinic Proton Beam Therapy Program.
Member at Large:
Charles Simone, MD
New York Proton Center
Charles B. Simone, II, MD, FACRO is the Chief Medical Officer of the New York Proton Center and a Full Member in the Department of Radiation Oncology at Memorial Sloan Kettering Cancer Center. He is an internationally recognized expert in the use of proton therapy to treat thoracic malignancies and for reirradiation, and in the development of clinical trial strategies and innovative research in thoracic radiation oncology and stereotactic body radiation therapy. He is a National Institutes of Health, National Science Foundation, and Department of Defense funded investigator who performs clinical and translational research investigating the benefits of proton therapy as part of multi-modality therapy for thoracic malignancies.
Prior to coming to NYPC, Dr. Simone was Chief of the Thoracic Oncology Service at the Hospital of the University of Pennsylvania, Director of the Penn Mesothelioma and Pleural Program, and Director of Clinical Research and Operations in the Department of Radiation Oncology at Penn. He was then appointment Medical Director of the Maryland Proton Treatment Center, and at the University of Maryland, he also served as Chair of the Clinical Research Committee for their Comprehensive Cancer Center, proton therapy Fellowship Director, and Director of the Stereotactic Radiation Therapy Program. He completed his undergraduate and medical school training at the University of Pennsylvania, internship in internal medicine, and residency training in radiation oncology at the National Cancer Institute, NIH, where he served as chief resident.